A detailed history of Cwm, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 830 shares of FLGT stock, worth $14,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
830
Previous 757 9.64%
Holding current value
$14,832
Previous $15,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$19.6 - $25.06 $1,430 - $1,829
73 Added 9.64%
830 $18,000
Q2 2024

Jul 09, 2024

BUY
$19.09 - $22.57 $12,045 - $14,241
631 Added 500.79%
757 $15,000
Q1 2024

Apr 05, 2024

SELL
$21.55 - $29.29 $4,051 - $5,506
-188 Reduced 59.87%
126 $3,000
Q4 2023

Feb 01, 2024

SELL
$23.64 - $30.27 $13,522 - $17,314
-572 Reduced 64.56%
314 $9,000
Q3 2023

Oct 11, 2023

SELL
$26.74 - $40.81 $10,214 - $15,589
-382 Reduced 30.13%
886 $24,000
Q2 2023

Aug 03, 2023

BUY
$28.52 - $40.7 $14,858 - $21,204
521 Added 69.75%
1,268 $47,000
Q1 2023

Apr 28, 2023

BUY
$29.39 - $36.27 $14,371 - $17,736
489 Added 189.53%
747 $23,000
Q4 2022

Feb 01, 2023

SELL
$29.23 - $40.28 $233 - $322
-8 Reduced 3.01%
258 $8,000
Q3 2022

Oct 27, 2022

SELL
$37.92 - $63.74 $38,185 - $64,186
-1,007 Reduced 79.1%
266 $10,000
Q2 2022

Jul 28, 2022

BUY
$47.98 - $62.75 $2,734 - $3,576
57 Added 4.69%
1,273 $69,000
Q1 2022

Apr 21, 2022

SELL
$49.85 - $96.11 $36,789 - $70,929
-738 Reduced 37.77%
1,216 $76,000
Q4 2021

Jan 31, 2022

BUY
$77.3 - $105.0 $20,407 - $27,720
264 Added 15.62%
1,954 $197,000
Q1 2021

Sep 15, 2021

SELL
$59.3 - $183.85 $8,064 - $25,003
-136 Reduced 7.45%
1,690 $156,000
Q1 2021

Apr 27, 2021

BUY
$59.3 - $183.85 $8,064 - $25,003
136 Added 8.05%
1,826 $176,000
Q4 2020

Sep 15, 2021

BUY
$31.01 - $52.1 $21,396 - $35,949
690 Added 69.0%
1,690 $156,000
Q4 2020

Jan 27, 2021

SELL
$31.01 - $52.1 $21,396 - $35,949
-690 Reduced 40.83%
1,000 $52,000
Q3 2020

Sep 15, 2021

BUY
$15.89 - $50.51 $26,854 - $85,361
1,690 New
1,690 $156,000
Q3 2020

Oct 19, 2020

SELL
$15.89 - $50.51 $26,854 - $85,361
-1,690 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$8.89 - $18.28 $15,024 - $30,893
1,690 New
1,690 $156,000
Q2 2020

Jul 22, 2020

SELL
$8.89 - $18.28 $15,024 - $30,893
-1,690 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$6.75 - $19.75 $11,407 - $33,377
1,690 New
1,690 $156,000
Q1 2020

Apr 28, 2020

SELL
$6.75 - $19.75 $11,407 - $33,377
-1,690 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$9.29 - $15.82 $15,700 - $26,735
1,690 New
1,690 $156,000
Q4 2019

Jan 27, 2020

SELL
$9.29 - $15.82 $15,700 - $26,735
-1,690 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$5.96 - $12.81 $10,072 - $21,648
1,690 New
1,690 $156,000
Q3 2019

Oct 22, 2019

SELL
$5.96 - $12.81 $10,072 - $21,648
-1,690 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$4.93 - $7.5 $8,331 - $12,675
1,690 New
1,690 $156,000
Q2 2019

Jul 31, 2019

SELL
$4.93 - $7.5 $8,331 - $12,675
-1,690 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$3.47 - $6.05 $5,864 - $10,224
1,690 New
1,690 $0

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.